Dr. Janet Ann Betchkal, MD

Dr. Betchkal practices at The Eye Associates Surgery Center Bradenton in Bradenton, Florida.

Dr. Betchkal's NPI, 1700881976, was assigned on June 15, 2005. Dr. Betchkal graduated from Rush Medical College in 1983. Dr. Betchkal holds Florida license MEOO56163.

Dr. Betchkal's primary practice is The Eye Associates Surgery Center Bradenton, at 6002 Pointe West Blvd, Bradenton, FL 34209. The practice phone is (813) 792-2020.

Dr. Betchkal's primary practice is The Eye Associates Surgery Center Bradenton in Bradenton, Florida. Dr. Betchkal is also affiliated with Ascension St. Vincent's Riverside. Dmand AI also links Dr. Betchkal to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Betchkal's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Betchkal practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Betchkal's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Betchkal is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Betchkal's licenses on file in 3 states: Florida, Pennsylvania and Illinois.

Dmand AI lists age-related macular degeneration, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and inflammation of iris among the conditions Dr. Betchkal treats.

CMS data shows 3,243 Medicare services from Dr. Betchkal across 11 procedure codes in 2024, for 496 Medicare patients. Medicare paid $200,422 for them. Every service was in an office.

CMS counts 496 Medicare patients who saw Dr. Betchkal in 2024. The largest group is 75 to 84, with 228 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Betchkal's median patient age at 74, with 54% women.

In 2024, Dr. Betchkal wrote 4,194 Medicare Part D claims for 538 patients. 43% of them were for generic drugs. CMS names the drug for 4,144 of them, across 21 drugs with 11 or more claims each, at $1,141,541 in total drug cost. In 2023, CMS named 4,119 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Betchkal for performance year 2024, reported individually. Dr. Betchkal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Betchkal, published from 2011 to 2012. The most frequent topics are Intraocular Pressure. Dr. Betchkal's most frequent co-author is M Fran Smith, MD.

CMS Open Payments shows 22 general payments to Dr. Betchkal from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Allergan Inc. paid the most, $1,131.

Dmand AI lists 2 awards for Dr. Betchkal, most recently CMS Stage 1 EHR in 2013.

Dr. Betchkal graduated from Rush Medical College in 1983. Dr. Betchkal is a member of AAO.

Dr. Betchkal is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.